{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:53:55Z","timestamp":1769579635626,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.jsbmb.2005.04.009","type":"journal-article","created":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T13:38:07Z","timestamp":1119361087000},"page":"151-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Long-term effects of aromatase inhibitors on bone"],"prefix":"10.1016","volume":"95","author":[{"given":"Richard","family":"Eastell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2005.04.009_bib1","doi-asserted-by":"crossref","unstructured":"The ATAC Trialists Group, Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359 (June (9324)) (2002) 2131\u20132139.","DOI":"10.1016\/S0140-6736(02)09088-8"},{"issue":"November (9)","key":"10.1016\/j.jsbmb.2005.04.009_bib2","first-page":"1802","volume":"98","author":"Baum","year":"2003","journal-title":"Cancer"},{"issue":"March (11)","key":"10.1016\/j.jsbmb.2005.04.009_bib3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"November (19)","key":"10.1016\/j.jsbmb.2005.04.009_bib4","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"August (8)","key":"10.1016\/j.jsbmb.2005.04.009_bib5","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jcem.87.8.8750","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","author":"Delmas","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9041","key":"10.1016\/j.jsbmb.2005.04.009_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"September (18)","key":"10.1016\/j.jsbmb.2005.04.009_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"September (9336)","key":"10.1016\/j.jsbmb.2005.04.009_bib8","first-page":"817","article-title":"First results from the international breast cancer intervention study (IBIS-I): a randomised prevention trial","volume":"360","author":"Cuzick","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jsbmb.2005.04.009_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(99)80251-4","article-title":"The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women","volume":"99","author":"Grey","year":"1995","journal-title":"Am. J. Med."},{"issue":"7\u20138","key":"10.1016\/j.jsbmb.2005.04.009_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/028418698430007","article-title":"Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer","volume":"37","author":"Resch","year":"1998","journal-title":"Acta Oncol."},{"issue":"April (4)","key":"10.1016\/j.jsbmb.2005.04.009_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/jcem.83.4.4688","article-title":"Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients","volume":"83","author":"Marttunen","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"May (5)","key":"10.1016\/j.jsbmb.2005.04.009_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.1994.12.5.992","article-title":"Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study","volume":"12","author":"Kristensen","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2005.04.009_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0169-6009(08)80220-6","article-title":"Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women","volume":"22","author":"Ward","year":"1993","journal-title":"Bone Miner."},{"issue":"January (1)","key":"10.1016\/j.jsbmb.2005.04.009_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women","volume":"14","author":"Powles","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2005.04.009_bib15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"January (1)","key":"10.1016\/j.jsbmb.2005.04.009_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/030089169608200114","article-title":"Effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women","volume":"82","author":"Barni","year":"1996","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.jsbmb.2005.04.009_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01806497","article-title":"Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen","volume":"37","author":"Kalef-Ezra","year":"1996","journal-title":"Breast Cancer Res. Treat."},{"issue":"November (5)","key":"10.1016\/j.jsbmb.2005.04.009_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002239900714","article-title":"Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer","volume":"65","author":"Marttunen","year":"1999","journal-title":"Calcif. Tissue Int."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2005.04.009_bib19","first-page":"S165","article-title":"Effect of anastrozole on bone density and bone turnover: results of the arimadex, tamoxifen, alone or in combination (ATAC) study","volume":"17","author":"Eastell","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2005.04.009_bib20","first-page":"S312","article-title":"Effect of anastrozole on bone mineral density: 2-year results of the ATAC trial","volume":"18","author":"Eastell","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"July (13)","key":"10.1016\/j.jsbmb.2005.04.009_bib21","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1200\/JCO.2002.20.13.3039","article-title":"Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact","volume":"20","author":"Bajetta","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"July (7)","key":"10.1016\/j.jsbmb.2005.04.009_bib22","first-page":"614","article-title":"Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention","volume":"11","author":"Harper-Wynne","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"January (1)","key":"10.1016\/j.jsbmb.2005.04.009_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1359\/jbmr.2002.17.1.172","article-title":"Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women","volume":"17","author":"Heshmati","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"July (4)","key":"10.1016\/j.jsbmb.2005.04.009_bib24","first-page":"3485","article-title":"Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs. megestrol acetate","volume":"23","author":"Martinetti","year":"2003","journal-title":"Anticancer Res."},{"issue":"August (8)","key":"10.1016\/j.jsbmb.2005.04.009_bib25","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/jcem.86.8.7736","article-title":"Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men","volume":"86","author":"Khosla","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jsbmb.2005.04.009_bib26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"October (4)","key":"10.1016\/j.jsbmb.2005.04.009_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S8756-3282(01)00584-1","article-title":"Association between endogenous hormones and sex hormone-binding globulin and bone turnover in older women: study of osteoporotic fractures","volume":"29","author":"Chapurlat","year":"2001","journal-title":"Bone"},{"issue":"October (10)","key":"10.1016\/j.jsbmb.2005.04.009_bib28","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1210\/jc.2002-020396","article-title":"Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women","volume":"87","author":"Rogers","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jsbmb.2005.04.009_bib29","first-page":"2239","article-title":"Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures","volume":"83","author":"Ettinger","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"September (11)","key":"10.1016\/j.jsbmb.2005.04.009_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","article-title":"Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group","volume":"339","author":"Cummings","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"September (9)","key":"10.1016\/j.jsbmb.2005.04.009_bib31","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1359\/jbmr.2000.15.9.1835","article-title":"Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study","volume":"15","author":"Chapurlat","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"November (21)","key":"10.1016\/j.jsbmb.2005.04.009_bib32","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"December (12)","key":"10.1016\/j.jsbmb.2005.04.009_bib33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.jsbmb.2005.04.009_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0002-9343(94)90065-5","article-title":"Diclofenac sodium inhibits bone resorption in postmenopausal women","volume":"96","author":"Bell","year":"1994","journal-title":"Am. J. Med."},{"issue":"October (4)","key":"10.1016\/j.jsbmb.2005.04.009_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S8756-3282(00)00361-6","article-title":"Use of nonsteroidal anti-inflammatory drugs and risk of fractures","volume":"27","author":"van Staa","year":"2000","journal-title":"Bone"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005001913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005001913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:50:55Z","timestamp":1760734255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076005001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":35,"journal-issue":{"issue":"1-5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0960076005001913"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.04.009","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of aromatase inhibitors on bone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}